RT Journal Article
T1 VCA in the Era of the COVID-19 Pandemic.
A1 Petruzzo, Palmina
A1 Kanitakis, Jean
A1 Sardu, Claudia
A1 Bassiri-Gharb, Bahar
A1 Morelon, Emmanuel
A1 Amer, Hatem
A1 Barret, Juan
A1 Burt, James
A1 Brandacher, Gerald
A1 Gomez, Tomas
A1 Kay, Simon
A1 Kaminska, Dorotha
A1 Kaufman, Christina L
A1 Kumar, Dinesh S
A1 Iglesias, Martin
A1 Iyer, Subramania
A1 Landin, Luis
A1 Lanzetta, Marco
A1 Lassus, Patrick
A1 Levin, Scott
A1 Papay, Francis
A1 Pomahac, Bohdan
A1 Sassu, Paolo
A1 Satbhai, Nilesh G
A1 Talbot, Simon
K1 Covid‑19
K1 Organ Transplantation
K1 Solid Organ Transplant
K1 Waiting List Mortality
K1 Transplant Recipients
K1 Transplant Activity Decline
K1 Pandemic Impact
K1 Geographic Variation
K1 Health Services Disruption
AB Since its onset in the beginning of 2020, the coronavirus disease 2019 (COVID-19) pandemic has impacted the transplantation community broadly. Indeed, the number of transplantations decreased dramatically and transplantations were temporarily shut down in many localities.1,2 The dramatic impact of the COVID-19 pandemic on solid organ transplant (SOT) recipients began to emerge with reports initially from China, Spain, and Italy. The prevalence of COVID-19 in SOT during the first pandemic wave varied geographically, but despite several reports, the effective incidence of the COVID-19 in SOT recipients remains unclear.2-5 Most relevant, solid organ transplantation (heart, liver, and kidney) rates declined, exposing candidates to an increased rate of waitlist mortality.1
PB Lippincott Williams & Wilkins
YR 2022
FD 2022
LK http://hdl.handle.net/10668/19870
UL http://hdl.handle.net/10668/19870
LA en
NO Petruzzo P, Kanitakis J, Sardu C, Bassiri Gharb B, Morelon E, Amer H, et al. VCA in the Era of the COVID-19 Pandemic. Transplantation. 2022 Apr 1;106(4):690-692.
DS RISalud
RD Jul 31, 2025